12 results  1 of 1 

1 Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation
Jieun Uhm
Blood Res.2023;58(S1):S109-S113.   Published online 2023 April 30     DOI: http://dx.doi.org/10.5045/br.2023.2023054
      
2 EGFR-TKI Combined with Pemetrexed versus EGFR-TKI Monotherapy in Advanced EGFR-Mutated NSCLC: A Prospective, Randomized, Exploratory Study
Weiguang Gu, Hua Zhang, Yiyu Lu, Minjing Li, Shuang Yang, Jianmiao Liang, Zhijian Ye, Zhihua Li, Minhong He, Xiaoliang Shi, Fei Wang, Dong You, Weiquan Gu, Weineng Feng
Cancer Res Treat.2023;55(3):841-850.   Published online 2023 February 13     DOI: http://dx.doi.org/10.4143/crt.2022.1438
      
3 Clinical Impact of Drug Adherence of Tyrosine Kinase Inhibitors in Children with Ph-Positive Acute Lymphoblastic Leukemia
Jun-Xia Wang, Miao-Miao Yang, Li-Peng Liu, Hui-Min Zhang, Meng-Chuan Wang, Yu-Wen Chen, Xiao-Ying Zang, Fang Hu
Cancer Res Treat.2023;55(3):1023-1030.   Published online 2023 February 6     DOI: http://dx.doi.org/10.4143/crt.2022.1618
      
4 Nilotinib-Induced Acute Interstitial Nephritis during the Treatment of Chronic Myeloid Leukemia
Min Jeong Kim
Kosin Med J.2021;36(2):153-160.   Published online 2021 December 31     DOI: http://dx.doi.org/10.7180/kmj.2021.36.2.153
      
5 Current Status and Future Perspective of the Treatment for Radioiodine Refractory Differentiated Thyroid Cancer
Young Kee Shong
Int J Thyroidol.2021;14(2):98-111.   Published online 2021 November 30     DOI: http://dx.doi.org/10.11106/ijt.2021.14.2.98
      
6 Real-world management of chronic myeloid leukemia in South Korea: the TARGET survey
Jieun Uhm, Kyoung Ha Kim, Hyewon Lee, Hawk Kim, Slader Cassandra, Inkyung Joo, Chul Won Jung
Blood Res.2021;56(1):31-37.   Published online 2021 January 28     DOI: http://dx.doi.org/10.5045/br.2021.2020260
      
7 Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma
In Kyoung Hwang, Seung Sook Paik, Seung Hyeun Lee
Cancer Res Treat.2019;51(1):158-168.   Published online 2018 April 2     DOI: http://dx.doi.org/10.4143/crt.2018.084
      
8 Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model
Pawel Chrom, Rafal Stec, Lubomir Bodnar, Cezary Szczylik
Cancer Res Treat.2018;50(1):103-110.   Published online 2017 March 3     DOI: http://dx.doi.org/10.4143/crt.2017.033
      
9 Recent Updates on the Management of Medullary Thyroid Carcinoma
Bo Hyun Kim, In Joo Kim
Endocrinol Metab.2016;31(3):392-399.   Published online 2016 August 26     DOI: http://dx.doi.org/10.3803/EnM.2016.31.3.392
   
10 The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma
Hye Ryun Kim, Jung Ryun Ahn, Jin Gu Lee, Doo Hee Bang, Sang-Jun Ha, Yun Kyoung Hong, Sun Mi Kim, Ki Chang Nam, Sun Young Rha, Ross A. Soo, Gregory J. Riely, Joo Hang Kim, Byoung Chul Cho
Yonsei Med J.2013;54(4):865-874.   Published online 2013 May 14     DOI: http://dx.doi.org/10.3349/ymj.2013.54.4.865
      
11 Novel EGFR-TK Inhibitor EKB-569 Inhibits Hepatocellular Carcinoma Cell Proliferation by AKT and MAPK Pathways
Heesue Kim, Ho Yeong Lim
J Korean Med Sci.2011;26(12):1563-1568.   Published online 2011 November 29     DOI: http://dx.doi.org/10.3346/jkms.2011.26.12.1563
      
12 Comparison of Gefitinib and Erlotinib for Patients with Advanced Non-Small-Cell Lung Cancer
Jin Hwa Lee, Kyoung Eun Lee, Yon Ju Ryu, Eun Mi Chun, Jung Hyun Chang
Tuberc Respir Dis.2009;66(4):280-287.   Published online 2009 April 30     DOI: http://dx.doi.org/10.4046/trd.2009.66.4.280
      

 1 of 1